At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
FDA approved pulse oximeter and DOVE device prototypedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single Center Study on the Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device
In Brief
A clinical study evaluating FDA approved pulse oximeter and DOVE device prototype for Hypoxic Events. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The purpose of this study is to asses the function of an oxygen sensor and the movement sensor in a novel device prototype.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypoxic Events
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJan 2022
Enrollment StartMay 2022
Primary CompletionDec 2024
Study CompletionDec 2024
TodayJul 2026
First PostedJan 20, 2022
Enrollment StartMay 20, 2022
Primary CompletionDec 21, 2024
Study CompletionDec 28, 2024
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 4.5 years ago
Interventions
FDA approved pulse oximeter and DOVE device prototypedevice
The objective is to assess reasonable detection of hypoxic episodes